Cara Therapeutics | CARA - Market Capitalization

Stock Price
3.29
Daily Change
-0.07 -2.08%
Monthly
-18.77%
Yearly
-80.16%
Q1 Forecast
3.41

Cara Therapeutics reported $186.4M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Cara Therapeutics USD 28M 11M Dec/2024
Cassava Sciences USD 83M 13M Mar/2026
Chugai Pharma JPY 13.84T 3.01T Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.58M 475.91M Mar/2026
CSL USD 71.32B 15.44B Mar/2026
Grifols EUR 2.02B 4.34B Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Pacira USD 1.06B 94M Dec/2025
Pfizer USD 153.96B 12.4B Mar/2026
RedHill Biopharma USD 1000K 6M Mar/2026
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024